The drug targets relapsed or refractory primary central nervous system lymphoma, a rare and aggressive form of non-Hodgkin lymphoma
A final tranche of €12 million will follow, contingent on positive pivotal study results, with the share price calculated according to an agreed formula
The Pre-Approval Inspection (PAI) was completed on February 13, 2026, and the company is initiating corrective actions.
Vanrafia, a potent endothelin A receptor antagonist, received accelerated approval in the US and China in 2025 for reducing proteinuria in adults with IgAN
Iberdomide has the potential to be the first approved CELMoD agent
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
The company’s consolidated revenues rose 17.5% year-on-year to Rs. 2,265 crore
PBGENE-DMD is designed to permanently correct mutations in the dystrophin gene between exons 45 and 55, the “hot-spot” region affecting roughly 60% of DMD patients
The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year
Garijo will be the first woman to lead Sanofi in its history
Subscribe To Our Newsletter & Stay Updated
